Clinical Trial Update: ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ATX-MS-1467 in relapsing-remitting multiple sclerosis; the study is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• ATX-MS-1467

Snippet

Sponsor: Apitope Technology (Bristol) Ltd. | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 1 | Status: COMPLETED | Results posted: 2015-02-16